Diabetes-induced retinopathy: An updated review on risk factors, diagnosis, and management strategies

Diabetes-induced retinopathy is a leading cause of visual impairment and blindness worldwide. This review provides an updated overview of the risk factors, diagnosis, and management strategies for diabetes-induced retinopathy. The pathogenesis of retinopathy in diabetes is multifactorial, involving both metabolic and vascular mechanisms. Several risk factors, including chronic hyperglycemia, hypertension, dyslipidemia, and duration of diabetes, contribute to the development and progression of retinopathy. Early detection and timely intervention are crucial for preventing vision loss and managing the disease effectively. Various diagnostic modalities, such as fundus photography, optical coherence tomography, and fluorescein angiography, play a pivotal role in the diagnosis and monitoring of retinopathy. Management strategies for diabetes-induced retinopathy encompass both medical and surgical interventions. Optimal glycemic control, blood pressure management, and lipid control are fundamental in preventing and slowing the progression of retinopathy. Additionally, novel therapeutic approaches, including anti-vascular endothelial growth factor (VEGF) agents, intravitreal steroids, and laser photocoagulation, are emerging as effective treatment options. This review aims to provide healthcare professionals with an updated understanding of the risk factors, diagnostic techniques, and management strategies for diabetes-induced retinopathy, ultimately promoting better patient care and visual outcomes